Skip to main content
Clinical Trials/CTRI/2012/12/003176
CTRI/2012/12/003176
Completed
N/A

Assessment of the efficacy of a 6-week randomized, controlled half-face treatment with topical formulae containing 4% ER2412 compared to placebo in healthy volunteers with oily skin.

OREAL RESEARCH0 sites37 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
OREAL RESEARCH
Enrollment
37
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
OREAL RESEARCH

Eligibility Criteria

Inclusion Criteria

  • Healthy male volunteers, aged 18 â?? 40 years
  • \-Skin phototype II \-V (Fitzpatrick)
  • \-Presenting an oily skin appearance on the face (sebum rate \>70 µg/cm2 30 min after degreasing on the forehead right and left)
  • \-Acne prone subjects showing the presence of facial acne (grade 2\-7 in the attached Leeds acne grade \- Appendix 1\), presenting at least 15 inflammatory lesions and at least 25 non\-inflammatory lesions on the face
  • \-Able to give written informed consent and to comply with the requirements of the study

Exclusion Criteria

  • \-Female subjects
  • \-Known hypersensitivity to any of the study drugs or constituents
  • \-Skin disorders affecting the study area which, in the supervisorâ??s / designatorâ??s judgment, would interfere with grading / assessment of skin response (e.g. severe acne grade 8\-9 in the Leeds Acne Grade, rosacea, eczema, seborrhoeic dermatitis, psoriasis, disorders of pigmentation, etc â?¦)
  • \-Use of systemic retinoids within the 6 months prior to participation in the study, and during the study
  • \-Any topical or systemic treatment that could interfere with the study treatments/assessments (topical benzoyl peroxide and other antiacne or antiseborreic products, antibiotics, corticosteroids, anti\-inflammatory drugsâ?¦) within the last 4 weeks prior to participation in the study, and during the study
  • \-Undergone a facial resurfacing procedure, i.e., chemical peel, laser resurfacing, dermabrasion, within the 6 months prior to participation in the study, and during the study
  • \-Any surgical treatment on the test areas
  • \-Subject reported or planning to sun\-bath or to overexpose to UV\-light (mountains sports, phototherapy, tanning salon useâ?¦) for aesthetic or therapeutic reason the month before the study start or during the study
  • \-Current use of immunosuppressive drugs and/or an organ transplant
  • \-Insulin\-dependent diabetes

Outcomes

Primary Outcomes

Not specified

Similar Trials